Rigel Pharma (RIGL.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec10

Rigel Pharmaceuticals Updates R289 Phase 1b Trial Data

21:07

Dec7

R289 Achieves 40% Success Rate in Treating Older Patients with Low-Risk Myelodysplastic Syndromes

14:53

Rigel Pharmaceuticals Announces Encouraging Results for R289 in Low-Risk MDS Patients

14:30

Nov5

Rigel Pharma released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 69.46 M (forecast USD 61.88 M), actual EPS USD 1.46 (forecast USD 0.9025)

00:00

Rigel Pharma released FY2025 9 Months earnings on November 4, 2025, After-Market EST, with actual revenue of USD 224.48 M and actual EPS of USD 5.37

00:00

Nov4

Rigel Pharmaceuticals Exceeds Q3 Revenue Expectations and Raises Full-Year Guidance

21:16

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 69.46 M, Net Income 27.9 M, EPS 1.46

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 101.69 M, Net Income 59.61 M, EPS 3.28

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 53.33 M, Net Income 11.45 M, EPS 0.63

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change